Severity of Maternal SARS-CoV-2 Infection in Pregnancy Predicts Neonatal Outcomes. 2023

Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
Neonatology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak had an enormous global impact. Pregnant women with SARS-CoV-2 appear to have higher morbidity and mortality. This study aimed to evaluate the effect of the severity of maternal SARS-CoV-2 infection on neonatal outcomes. The clinical and laboratory data of 40 women and neonates evaluated retrospectively. This retrospective study showed that SARS-CoV-2 infection had an adverse impact on neonatal outcomes proportionally with the maternal disease severity including increased prematurity rates, postnatal resuscitation need, prolonged hospital stay and longer ventilatory support requirement in infants born to mothers with moderate or severe disease. Maternal disease severity had adverse effects on neonatal outcomes. The severity of maternal disease was found to be associated with increased rates of prematurity, requirement of postnatal resuscitation, prolonged hospital stay, and longer ventilatory support. · SARS-CoV-2 pandemic is a problem for pregnant women.. · Vertical transmission has been shown in limited studies.. · Maternal disease severity may have impact on neonatal outcomes..

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
May 2021, JAMA,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
February 2023, Seminars in fetal & neonatal medicine,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
March 2022, Clinical obstetrics and gynecology,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
September 2022, Viruses,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
January 2022, Neonatology,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
March 2023, BMJ open,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
January 2020, Journal of pregnancy,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
May 2022, JAMA,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
August 2022, International journal of environmental research and public health,
Beril Yasa, and Seyma Memur, and Dilek Yavuzcan Ozturk, and Onur Bagci, and Sait Ilker Uslu, and Ibrahim Polat, and Merih Cetinkaya
May 2021, American journal of perinatology,
Copied contents to your clipboard!